





BMDM were seeded in 24-well culture plates, cultivated in RPMI medium (11875085, Thermo Fisher 
Scientific), and infected with E. coli HB101 (MOI 100) 17. One hour post-infection, cells were washed 
twice with PBS and incubated in medium containing 100 µg/mL gentamicin (Sigma; #G1264) for two 
additional hours. Where indicated, 40 mM NaCl or mitochondrial inhibitors were added to the medium. 
Subsequently, the infected cells were lysed in PBS containing 0.1% Triton-X (VWR; 28880.293) and 
0.05% Tween 80 (Merck; #8.22187.0500). Bacterial survival was assessed by plating serial dilutions on 
Müller-Hinton-II agar plates and counting colony-forming units (CFUs) after one day of incubation. 
 
Griess Assay 
Griess Assay was performed with supernatants of BMDM. Supernatants were diluted with Griess 
Reagents I (1% (w/v) sulfanilamide (S9251, Sigma by Merck) and 5% (v/v) H3PO4 in water) and II 
(1mg/mL N-(α-naphthyl-)ethylenediamine dihydrochloride (N9125, Sigma by Merck) in water) at a ratio 
of 2:1:1. Absorbance was measured at 550 nm on a Spectra Fluor plate reader (Tecan). NO2- 
concentrations were quantified by parallel measurement of a NaNO2 standard curve. 
 
RNA Purification, Preparation of cDNA and Quantitative Real-Time Polymerase Chain Reaction 
Total RNA was isolated from BMDM with QIAzol lysis reagent (79306, Qiagen) and the RNeasy Mini Kit 
(74106, Qiagen). Samples were treated with DNase (79254, Qiagen), according to the manufacturer's 
instructions, and eluted in RNase/DNase-free water. RNA quality and concentration were measured 
with the NanoDrop Spectrophotometer ND-1000 from PeqLab. The High Capacity cDNA Reverse 
Transcription Kit (4368813, Applied Biosystems by Thermo Fisher Scientific) was used to reverse 
transcribe RNA into cDNA according to the manufacturer's protocol. 
Quantitative real-time polymerase chain reaction (qPCR) was performed as TaqMan assay (4367846, 
Applied Biosystems by Thermo Fisher Scientific) with sequence specific DNA probes or as SYBR green 
assay (4385614, Applied Biosystems by Thermo Fisher Scientific). Progression of qPCR was detected 
with the QuantStudio 3 Real-Time PCR System (Applied Biosystem by Thermo Fisher Scientific) and 
analysed with the QuantStudio Design & Analysis Software v1.4.3 (Applied Biosystems by Thermo 
Fisher Scientific). Gene expression was normalized to expression levels of the ribosomal RNA gene 







































































Human macrophages were lyzed in RLT buffer (79216, Qiagen) containing β-mercaptoethanol and RNA 
was isolated from the lysates using the RNeasy micro Kit (74004, Qiagen). RNA was reversely 
transcribed using the qScript cDNA SuperMix (95048 Quanta Biosciences). Quantitative real-time PCR 
was performed with the Taqman system (Applied Bioscience) according to manufacturer’s instructions. 
Samples were measured on the Step ONE Plus RT-PCR machine (Applied Biosciences). The following 
probes were used: GAPDH: Hs99999905_m1, IL-8: Hs00174103_m1, TNFα: Hs00174128_m1, Ccl18: 
Hs00268113_m1, ALOX15: HS00993765_g1, Ccl17: Hs00171074_m1, IL-6: Hs00174131_m1. 
 
Determination of Intracellular ATP 
Quantification of intracellular ATP of BMDM, human blood-derived monocytes and human macrophages 
was performed using the ATPlite Luminescence Assay System (6016941, PerkinElmer). Cell 
supernatant was discarded, cells lysed and luminescence measured according to the manufacturer’s 
protocol with a FLUOstar OPTIMA reader (BMG Labtech) or a Spectra Fluor plate reader (Tecan). 
 
Determination of Mitochondrial Membrane Potential 
Mitochondrial membrane potential was determined by using the TMRE-Mitochondrial Membrane 
Potential Assay Kit (ab113852, Abcam). 
BMDM and PBMC-derived monocytes were cultivated (and activated) as described above. During the 
last hour of stimulation, cells were incubated for 60 min at 37°C with MitoTracker Green FM (M7514, 
Invitrogen by Thermo Fisher Scientific) at a final concentration of 100nM and Hoechst (B2261, Sigma 
by Merck) at a final concentration of 10µg/mL, both directly into cell culture medium. TMRE staining was 
performed during the last 20 min at 37°C at a concentration of 40nM into cell culture medium. Cells were 
then washed with PBS, detached (in case of BMDM) with 2mM EDTA in PBS on ice and analysed by 
flow cytometry (BD LSR-Fortessa using FACSDiva and FlowJo).  
Mitochondrial membrane potential was also determined in isolated mitochondria. Therefore, 1x10e7 
BMDM were lysed in the Miltenyi Biotec Mitochondrial Lysis buffer, supplemented with 5% (v/v) 
cOmplete Protease Inhibitor Cocktail (04693132001, Roche by Merck). Cells were lysed with a 30G 
needle on ice, magnetically labelled and mitochondria isolated using the Mitochondria Isolation Kit (130-
096-946, Miltenyi Biotec) and the QuadroMacs Separator according to the manufacturer's instructions. 
Isolated mitochondria were re-suspended in a mitochondrial respiration buffer containing 180 mM 
sucrose (7651, Merck), 0.1 mM EDTA (E-4884, Sigma by Merck), 60 mM KCl (4936.1000, Merck), 10 
mM K3PO4 (A442903, Merck), 12 mM K2CO3 (P5833-500G), 2mM K-lactate (60389-250ML-F), 2 mM 
Na-pyruvate (11360.039, Gibco), 2 mM K3-citrate (1548225-1G), 2mM K-2-oxo-glutaric acid (K2000-
5G), 1 mM Na2-fumarate (8205840100), 2 mM Na2-succinate (W327700), 1 mM malate (46940-U), 1 
mM glutamine (25030-081, Gibco by Thermo Fisher Scientific), 0.035 mM ADP (A5285-1G), 1 mM 
glycine, 1 mM alanine, 1 mM asparagine, 1 mM aspartic acid, 1 mM glutamate, 1 mM proline, and 1 mM 
serine (non-essential amino acids, 11140050, Gibco by ThermoFisher Scientific). They were then 
stained and analysed as described above for cells. 
Human macrophages were analysed by fluorescence plate reading. In brief, macrophages were 
cultivated and stimulated in black 96 well plates with transparent bottom (655097, Greiner). After 
washing the cells, TMRE was applied at 80nM solved in 0.2% BSA/PBS for 30 minutes at 37°C. Wells 
were washed twice and measured at the FLUOstar OPTIMA reader (BMG Labtech) with the following 
settings: Ex-540nm, Em-590. 
 
Intracellular Sodium Measurement 
Human monocytes (106 cells) were stimulated with HS for 60 min, harvested and washed with iso-
osmolal sucrose solution. The pellet was lysed as described earlier [Neubert et al. PlosONE 2020] and 
total Na+ was determined by atomic absorption spectrometry (Thermo Scientific, iCE 3000 Series). 
 
Transmission Electron Microscopy 
BMDM were grown and stimulated as indicated above, washed with PBS, detached with 2mM EDTA in 
PBS and gentle scraping, and cell pellet fixed with 2.5% glutaraldehyde (G5882, Sigma by Merck) in 
PBS for 2h at 4°C. Tonicity during washes, detachment, and fixation was adjusted to +40mM NaCl for 
the respective high salt groups. The pellets were rinsed several times in the same buffer and postfixed 
in 1% osmium tetroxide (201030, Sigma by Merck) buffered in the respective buffer (normal salt or high 
salt) for 30 min at 4°C. 
The material was subsequently dehydrated in an acetone series and embedded in epoxy resin using 
the EMbed-812 kit (E14121, Science Services). Series of silver to grey interference color ultra-thin 
sections (50-65 nm) were made with a diamond knife (Diatome Ultra 45°) mounted on a Leica Ultracut 
S ultramicrotome and placed on formvar covered single-slot grids. The sections were stained with 2% 
uranyle acetate (E22400, Science Services) and 2.6% lead citrate (E17810, Science Services) after 
Reynolds in an automated TEM stainer (QG-3100, Boeckeler Instruments). Sections were examined 
and imaged under a ZEISS EM10CR with DITABIS imaging plates. Series of 20 to 30 sections of a 
single cell from each sample were recorded at higher magnification (12500 to 20000 times) and used 
for partial reconstruction of mitochondria. Images were aligned using IMOD and IMOD-align (Boulder 
Laboratories). Aligned TEM images were then used to reconstruct the mitochondrial network within a 
±1.5µm thick segment of each cell using the software Amira (6.5.0). 
 
Determination of Intracellular FAD 
Quantification of intracellular FAD of BMDM and human monocytes was performed using the Flavin 
Adenine Dinucleotide (FAD) Assay Kit (ab204710, Abcam). Cells were cultivated and activated as 
described above. After washing with ice cold PBS, cells were lysed in the supplied FAD Assay Buffer, 
centrifuged for 5 min at 10000xg and 4°C, and supernatant deproteinized by filtering through 10kDa 
spin columns (Nanosep Centrifugal Devices with Omega Membrane 10K, OD010C34, Pall Life 
Science). Samples were then treated according to the kit’s instructions and absorbance at 570 nm 
measured in kinetic mode on a Spectra Fluor plate reader (Tecan). 
 
Electron Transport Chain Complex Assays 
The activity of mitochondrial electron transport chain complexes was detected by using different kits. 
Complex I activity was determined with the colorimetric Complex I Enzyme Activity Microplate Assay Kit 
(ab109721, Abcam). Cell supernatant was discarded, cells lysed with the supplied lysis buffer and 
protein concentration determined with the NanoDrop Spectrophotometer ND-1000 from PeqLab. Protein 
concentration was adjusted to 5mg/mL and 200 µL per well of the supplied 96-well plate were added 
and incubated for 3h at room temperature. Complex I NADH dehydrogenase was thereby bound to the 
plate. After thorough washing, the supplied reaction mix as well as increasing concentrations of NaCl 
(4mM, 1mM, and 0.25mM NaCl) were added to the plate. Finally, NADH was added to the mix and 
absorbance at 450 nm was measured in kinetic mode on a Spectramax 190 plate reader. 
Similarly, Complex II activity was determined by immunoprecipitation with the Complex II Enzyme 
Activity Microplate Assay Kit (ab109908, Abcam). Cell and mitochondrion independent Complex II 
activity was assessed by incubating with succinate and ubiquinone according to the manufacturer’s 
instructions and measuring absorbance at 600 nm in kinetic mode on a Spectra Fluor plate reader 
(Tecan). For high salt conditions, 4mM, 1mM, and 0.25mM NaCl were added to the reaction. 
Complex II/III activity was assessed using the MitoTox Complex II + III OXPHOS Activity Assay Kit 
(ab109905, Abcam) according to the manufacturer’s instructions. Activity solution was mixed with 
increasing concentrations of NaCl (serial dilutions from 64mM to 0.0625mM NaCl) or Antimycin A as 
positive control (serial dilutions from 352nM to 0.3438nM). Bovine heart mitochondria were added and 
absorbance at 550nm was measured in kinetic mode on a Spectramax 190 plate reader. Complex II/III 
activity was calculated relative to the solvent control (water or DMSO, respectively). Opposed to the 
Complex I and Complex II assays, this assay was performed in intact (bovine) mitochondria. 
Complex IV activity was assessed with the MitoTox Complex IV OXPHOS Activity Assay Kit (ab109906, 
Abcam). Intact (bovine) mitochondria were incubated with reduced cytochrome C and absorbance at 
550nm was measured in kinetic according to the manufacturer’s instructions on a Spectramax 190 plate 
reader. 
 
Determination of Intracellular NAD and NADH 
Quantification of intracellular total NAD and NADH of BMDM was performed using the NAD/NADH 
colorimetric assay kit from Abcam (ab65348). Cell supernatant was discarded, cells lysed and lysate 
split into two equal parts. One part was heated at 60°C for 30 min, in order to decompose all NAD+. 
Absorbance of both parts (incubated with the provided reaction mix) was measured at 450 nm according 
to the manufacturer’s protocol on a Spectramax 190 plate reader. The assay is based on the conversion 
of NAD+ to NADH by the developer added. Thereby, NADH is detected in the heated half of the lysate 
(where no NAD+ is present), whereas total NAD is detected in the untouched half. The amount of NAD+ 
can be calculated as the difference between total NAD and NADH. 
 
Transwell assay 
Human macrophages were seeded in 24 well plates and stimulated as indicated for 24 hours. Transwell 
inserts with a pore size of 3 μm (662630, Greiner) were inserted and 2x10e5 CD4+ T cells loaded in the 
insert. After 24h incubation time cells were harvested and subjected to flow cytometry analysis. CD4+ 
T cells were sorted by using the EasySep CD4+ T cell isolation kit (17952, Stemcell Technologies) 
according to manufacturer’s protocol. 
 
Human PBMC killing 
PBMCs were obtained from healthy donors using density gradients and blood-derived monocytes were 
isolated as described above (ethical approval 20-1707-101; Ethikkommission an der Universität 
Regensburg). Cells were seeded in 24 well plates and infected with E. coli HB101 (MOI 100; as 
described above) for 1h ± 40 mM NaCl. Subsequently, extracellular bacteria were removed by washing 
with PBS and cells were incubated for 2h in 100 µg/ ml Gentamicin. Cells were lysed and serial dilutions 
containing intracellular bacteria were plated on Müller-Hinton II agar plates. CFU were counted and 





Table I: Antibodies, bacteria, biological samples, chemicals, commercial assays, experimental models, 
and software used for this study, listed with their respective source and identifier.  
REAGENT or RESOURCE SOURCE IDENTIFIER 
Antibodies 
FITC-CD11b anti-mouse BD Biosciences 553310 
FITC-CD16, anti-human Miltenyi biotec 130-106-703 
PB-F4/80, anti-mouse eBioscience by 
Thermo Fisher 
Scientific   
48-4801-80 
PE-Vio 770 CD14, anti-human   Miltenyi biotec  130-110-579 
PerCP-Vio700 HLA-DR Miltenyi biotec 130-095-291 
Bacterial and Virus Strains  
E. coli HB101 55 N/A 
Biological Samples 
Human peripheral blood mononucleated cells In-house N/A 
Murine bone marrow cells In-house N/A 
Chemicals, Peptides, and Recombinant Proteins 
Ammonium chloride Merck 1145.0500 
Adenosine diphosphate   Sigma by Merck   A5285 
Adult horse serum Cell Concepts S-HEU03-I 
Antimycin A   Sigma by Merck   A8674 
BD FACSClean   BD Biosciences   340345 
BD FACSFlow   BD Biosciences   342003 
BD FACSRinse   BD Biosciences   340346 
BD FACSSheath solution   BD Biosciences   336911 
BD FACSShutdown solution   BD Biosciences   334224 
Beta-mercaptoethanol   Sigma by Merck   M3148 
bisBenzimide H 33342 trihydrochloride (Hoechst) Sigma by Merck B2261 
Carbonyl cyanide 4-(trifluoromethoxy)phenylhydrazone 
(FCCP)   
Sigma by Merck   C2920 
Chloroform   Merck   102445 
CM-H2 DCFDA Invitrogen by Thermo 
Fisher Scientific 
C6827 
Complete protease inhibitor cocktail     Roche Diagnostics 
GmbH 
1836145 
Dimethyl malonate Sigma by Merck 136441 
DMEM, high glucose, with sodium pyruvate and L-
glutamine  
Gibco by Thermo 
Fisher Scientific   
41966-029 
DMEM, without glucose and sodium pyruvate, with L-
glutamine  
Gibco by Thermo 
Fisher Scientific   
11966-025 
DMEM, without glucose, L-glutamine and sodium 
pyruvate  
Gibco by Thermo 
Fisher Scientific   
A14430-01 
Dimethylsulfoxide (DMSO) Sigma by Merck   D4540 
Ethylenediaminetetraacetic acid (EDTA)   Sigma by Merck   E-4884 
Fast SYBR Green Master Mix   Applied Biosystems by 
Thermo Fisher 
Scientific   
4385614 
Fetal bovine serum  Biochrom by Merck   S0615 
Fetal bovine serum Biowest S1400 
Gentamicin Sigma by Merck G1264 
Glucose (D(+)-)  Carl Roth   X997.2 
Glucose (U-13C6 D-)   Cambridge Isotope 
Laboratories   
CLM-1396-PK 
Glutamine (L-)   Gibco by Thermo 
Fisher Scientific   
25030-081 
Glutamine (13C5 L-)   Cambridge Isotope 
Laboratories   
CLM-1822-H-PK 
Glutaraldehyde Sigma by Merck  G5882 
HEPES 1M   Gibco by Thermo 
Fisher Scientific  
15630-056 
IFNγ, human Peprotech 300-02 
IL-4, human Immunotools 113040045 
IL-4, mouse R/D Systems by bio-
techne   
404-ML-010 
IL-13, mouse Invitrogen by Thermo 
Fisher Scientific   
PMC0134 
Isofluran CP   cp-pharma   1214 
Lead citrate   Science Services   E17810 
LPS from E. coli o111:B4   Sigma by Merck   L3024 
LPS, ultrapure  Invivogen tlrl-3pelps 
M-CSF Peprotech 300-25 
Malic acid   Sigma by Merck   46940-U 
Methanol   Carl Roth   HN41.2 
Methoxyamine hydrochloride   Sigma by Merck   M6524 
MitoTracker Green FM   Invitrogen by Thermo 
Fisher Scientific   
M7514 
N5,N6-bis(2-fluorophenyl)-[1,2,5]oxadiazolo[3,4-
b]pyrazine-5,6-diamine (BAM15)  
Sigma by Merck SML1760-5MG 
N-(α-naphthyl-)ethylenediamine dihydrochloride Sigma by Merck N9125 
N-methyl-N-trimethylsilyl-trifluoroacetamide (MSTFA)   Macherey-Nagel   701270.201 
Non-essential amino acids   Sigma by Merck   M7145 
Oligomycin A   Sigma by Merck   75351 
Osmium tetroxide   Sigma by Merck   201030 
PBS without CaCl2 and MgCl2  Sigma by Merck   D8537 
Penicillin/Streptomycin  Gibco by Thermo 
Fisher Scientific 
15140-122 
Potassium 2-oxo-glutaric acid   Sigma by Merck   K2000 
Potassium carbonate   Sigma by Merck   P5833 
Potassium chloride   Carl Roth   6781.1 
Potassium citrate   Sigma by Merck   1548225 
Potassium lactate   Sigma by Merck   60389 
Potassium phosphate   Sigma by Merck   P5629 
Pyridine   Carl Roth   9729.3 
QIAzol Lysis Reagent   Qiagen   79306 
Rotenone   Sigma by Merck   R8875 
RPMI medium Gibco by Thermo 
Fisher Scientific 
11875085 
Seahorse XF base medium   Agilent   102363-100 
Sodium bicarbonate Merck 017 K13779929 
Sodium chloride    Carl Roth   9265.1 
Sodium Dodecylsulfate   Sigma by Merck   L4509 
Sodium fumarate   Sigma by Merck   8205840100 
Sodium pyruvate Gibco by Thermo 
Fisher Scientific 
11360070 
Sodium succinate   Sigma by Merck    W327700 
Sucrose   Sigma by Merck   S0389 
Sulfanilamide Sigma by Merck S9251 




Trans-Cinnamic acid   Sigma by Merck   133760 
Tris   Carl Roth   4855.2 
Triton X-100   Sigma by Merck   T9284 
Triton X-100 VWR 28880.293 
Trypan blue 0.5%   PromoCell PK-CA902-1209 
Trypsin/EDTA   Sigma by Merck   59417C 
Tween 80 Merck 8.22187.0500 
Uranyl acetate   Science Services   E22400 
X-VIVO 15 medium Lonza BE02-060F 
Commercial Assays 
ATPlite Luminescence Assay System     PerkinElmer 6016941 
Complex I Enzyme Activity Microplate Assay Kit Abcam ab109721 
Complex II Enzyme Activity Microplate Assay Kit Abcam ab109908 
EMbed-812 Kit  Science Services E14121 
EasySep CD14 Positive Selection kit II Stemcell Technologies 17858 
Flavin Adenine Dinucleotide (FAD) Assay Kit Abcam ab204710 
High Capacity cDNA Reverse Transcription Kit Applied Biosystems by 
Thermo Fisher 
Scientific   
4368813 
LIVE/DEAD Fixable Aqua Dead Cell Stain kit, for 405 nm 
excitation 
Invitrogen by Thermo 
Fisher Scientific 
L34966 
Mitochondria Isolation Kit 
 
Miltenyi Biotec 130-096-946 
MitoTox Complex II + III OXPHOS Activity Assay Kit Abcam ab109905 
MitoTox Complex IV OXPHOS Activity Assay Kit Abcam ab109906 
NAD/NADH Assay Kit (Colorimetric) 
 
Abcam ab65348 
Pan Monocyte Isolation Kit human Miltenyi Biotec 130-096-537 
qScript cDNA SuperMix Quanta Biosciences 95048 
RNase-free DNase Set 
 
Qiagen 79254 
RNeasy micro Kit Qiagen 74004 
RNeasy Mini Kit 
 
Qiagen 74106 
Seahorse XFe96 FluxPak Agilent 102416-100 
TMRE-Mitochondrial Membrane Potential Assay Kit Abcam ab113852 
Experimental Models: Cell Lines 
L-929, NCTC clone 929, strain C3H/An 
  
ATCC by LGC 
Standards 
ATCC CCL-1 
Experimental Models: Organisms/Strains 
C57BL/6J mice, wild type, 9 to 12-week old, male Harlan Laboratories  
C57BL/6J mice, wild type, 9 to 12-week old, male Charles River  
Software and Algorithms 
BD FACSDiva BD Biosciences  
ChromaTOF 5.0 LECO Corporation  
FlowJo 10.5.3 Tree Star by BD 
Biosciences 
 
MAUI-SILVIA Proteomics and 
Metabolomics 
Platform, Max-








Prism Version 8 GraphPad  




R 3.5.1 GNU General Public 
License 
 
RStudio GNU General Public 
License 
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Figure I, A Representative flow cytometric staining as purity control for F4/80+, CD11b+ murine BMDM. 
B-D, BMDM were treated for 3h with LPS or IL4+IL13, under normal salt (NS) or HS conditions. B, Basal 
extracellular acidification rate (ECAR) (pooled data n=10 from 3 independent experiments). Data is 
depicted as box and whisker with min to max. Significance was analyzed by Mann-Whitney test. C, 
Representative mitochondrial stress test, showing oxygen consumption rate (OCR) over time. D, 
Maximal OCR as in (B). Significance was analyzed by unpaired two-tailed t-test for M(LPS) and by 
Mann-Whitney test for M(IL4+L13). E, Representative flow cytometric staining of TMRE in MitoTracker 
Green+, Hoechst+ murine BMDM. F, Representative flow cytometric staining as purity control for 














































































































































































































































































































































































Figure II, A Glucose-derived 13C-label incorporation into Lac in 24h-treated M(LPS) and M(IL4+IL13) 
macrophages in dependency of the U13C6-Glc labelling duration (10-60 min). B-I, BMDM were treated 
for 3h (B-E) or 24h (F-I) with LPS or IL4+IL13, under normal salt (NS) or HS conditions. 13C-glutamine 
labeling was performed during the last hour of activation. Data (n=5 each) is depicted as box and whisker 
with min to max. Significance was analyzed by unpaired, two-tailed t-test for B-F, H, I or Mann-Whitney 
test for G. B, D, F, H, 13C-glutamine derived succinate (m+4). C, E, G, I, 13C-glutamine derived fumarate 
(m+4). J, K, Heatmaps showing relative quantities of 13C-glucose derived 13C-Lac, 13C-Cit, total Ita, and 
13C-Mal (J), as well as relative gene expression of Ldha, Pdha, and Pcx (K) in BMDM activated for 3h 
and 24h with LPS or IL4+IL13, under NS or HS conditions, in relation to untreated M0 macrophages 
(n=6 for each time point and group). 13C-glucose labeling was performed during the last hour of 
activation.  



























































































































































































































































































































































Figure III, A, B, relative gene expression of M1 marker genes Ccl5, Tnf, Irf5, Cox2, Nos2, Slamf1, 
Nlrp3, and M2 marker genes Arg1, Irf4, Chil3, Retnla1, Mgl2, Mrc1 normalized to 18S in murine BMDM 
activated for 1h, 3h, 6h, and 24h with LPS or IL4+IL13 under NS or HS conditions (pooled data n=12 
from 2 independent experiments). A, heatmap displaying the impact of LPS or IL4+IL13 activation over 
time relative to untreated M0 BMDM (as logarithmic fold change (FC)). A nested model test, treating 
HS treatment as covariate, was performed. B, heat map displaying the impact of HS relative to the NS 
equivalent at the same time point (as logarithmic delta). Kruskal-Wallis test with Mann-Whitney U post-
hoc test, comparing normal salt to HS to each time point separately for each activation group was 
performed. FDR-correction was performed via Benjamini-Hochberg procedure, with · for q<0.1, * for 
q<0.05, ** for q<0.01, and *** for q<0.001. C, Nitrite in the supernatant of murine BMDM activated for 
24h with LPS under NS or HS conditions, as well as untreated M0. Data (n=6, one out of two 
independent experiments) is depicted as box and whisker with min to max. Significance was analyzed 
by one-way ANOVA with Tukey’s post-hoc test. D, Relative gene expression of Il6, Il8, and Tnf in human 
macrophages activated for 24h with LPS+IFN under NS or HS conditions (n=6 each for IL6 and Il8, 
n=5 each for Tnf). E, Relative gene expression of Alox15, Cc17, and Ccl18 in human macrophages 
activated for 24h with IL4 under NS or HS conditions (n=7 each for Alox15, n=5 each for Ccl17 and 
Ccl18). Data in D, E, is shown as donor-paired mean and was analyzed by paired, two-tailed t-test (Il6, 
Il8, Alox15, Ccl17) or Wilcoxon matched-pairs signed rank two-tailed test (Tnf, Ccl18). F, 
Representative E. coli growth under NS, HS, and NS+BAM15 treatment. G, H, Representative cell 
viability of murine BMDM (G) and human monocytes (H) under NS, HS, and NS+BAM15 treatment, 









































































































































































































































Figure IV, A, B, Healthy volunteers underwent an intervention study and consumed 6g of salt 
additionally to their habitual diet for 14 days. Monocytes were analyzed by flow cytometry at four different 
time points: baseline, after 3 days and 14 days on high salt diet, and 14 days after the end of the 
intervention (day 28). A, representative gating strategy in PBMCs for the different monocyte subsets 
(identified by CD14, CD16, and HLA-DR). B, monocyte subsets analyzed are classical monocytes 
(CD14+ CD16-), intermediate monocytes (CD14+ CD16+) and non-classical monocytes (CD14- CD16+). 
No significant (ns) differences were detected by repeated measures ANOVA. 
